Related Experiment Video
Updated: Jul 10, 2026

Prion Safety Laboratory Swipe Test
Published on: February 14, 2025
A novel phenotype of sporadic Creutzfeldt-Jakob disease
G Giaccone1, G Di Fede, M Mangieri
1Istituto Nazionale Neurologico Carlo Besta, via Celoria 11, Milano 20133, Italy. giaccone@istituto-besta.it
Abstract:
An atypical case of sporadic Creutzfeldt-Jakob disease (CJD) is described in a 78-year-old woman homozygous for methionine at codon 129 of the prion protein (PrP) gene. The neuropathological signature was the presence of PrP immunoreactive plaque-like deposits in the cerebral cortex, striatum and thalamus. Western blot analysis showed a profile of the pathological form of PrP (PrP(Sc)) previously unrecognised in sporadic CJD, marked by the absence of diglycosylated protease resistant species. These features define a novel neuropathological and molecular CJD phenotype.
Insights
This study details an unusual case of sporadic Creutzfeldt-Jakob disease (CJD) in a 78-year-old woman. The patient presented a novel prion protein (PrP) profile and unique neuropathological findings, defining a new CJD phenotype.
Area of Science:
- Neurology
- Neuroscience
- Prion Diseases
Background:
- Sporadic Creutzfeldt-Jakob disease (sCJD) is a rare, fatal neurodegenerative disorder.
- Prion protein (PrP) gene mutations and polymorphisms influence disease presentation.
- Understanding sCJD phenotypes is crucial for diagnosis and research.
Observation:
- An atypical sCJD case in a 78-year-old female homozygous for methionine at codon 129 of the PrP gene.
- Neuropathology revealed PrP immunoreactive plaque-like deposits in the cerebral cortex, striatum, and thalamus.
- Western blot analysis identified a unique PrP(Sc) profile, notably lacking diglycosylated protease-resistant species.
Findings:
- The observed neuropathological and molecular features represent a novel sCJD phenotype.
- This case expands the known spectrum of prion protein aggregation and disease manifestation.
- The absence of diglycosylated PrP(Sc) species is a distinguishing molecular marker.
Implications:
- This novel phenotype may require adjusted diagnostic criteria for sCJD.
- Further research into this specific PrP profile could elucidate disease mechanisms.
- Identifying distinct CJD phenotypes aids in understanding prion biology and developing targeted therapies.
Related Concept Videos
Huntington Disease l: Introduction
Cryptococcal Meningitis
Alzheimer Disease ll: Pathophysiology
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Encephalitis ll: Pathophysiology

